Literature DB >> 12924664

Interferon-alpha for reinfection with hepatitis C virus in two patients with chronic hepatitis C who had responded to previous therapies.

Norio Akuta1, Fumitaka Suzuki, Akihito Tsubota, Yoshiyuki Suzuki, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Yuzo Miyakawa, Hiromitsu Kumada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12924664     DOI： 10.1023/a:1024796630509

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  22 in total

1.  Antibodies to hepatitis C virus in prospectively followed patients with posttransfusion hepatitis.

Authors:  S D Lee; S J Hwang; R H Lu; K H Lai; Y T Tsai; K J Lo
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

2.  Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.

Authors:  J M Pawlotsky; M Pellerin; M Bouvier; F Roudot-Thoraval; G Germanidis; A Bastie; F Darthuy; J Rémiré; C J Soussy; D Dhumeaux
Journal:  J Med Virol       Date:  1998-04       Impact factor: 2.327

Review 3.  Factors predictive of a beneficial response to therapy of hepatitis C.

Authors:  G L Davis; J Y Lau
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

4.  Dynamic changes in hepatitis C virus genotypes and sequence patterns in plasma donors exposed to reinfection.

Authors:  S Zhang ; Z Hui; H Li ; Z Qi ; A Widell
Journal:  J Med Virol       Date:  2001-03       Impact factor: 2.327

5.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

6.  Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus.

Authors:  K Yoshioka; S Kakumu; T Wakita; T Ishikawa; Y Itoh; M Takayanagi; Y Higashi; M Shibata; T Morishima
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

7.  Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs.

Authors:  L M Jarvis; H G Watson; F McOmish; J F Peutherer; C A Ludlam; P Simmonds
Journal:  J Infect Dis       Date:  1994-10       Impact factor: 5.226

8.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey.

Authors:  F McOmish; P L Yap; B C Dow; E A Follett; C Seed; A J Keller; T J Cobain; T Krusius; E Kolho; R Naukkarinen
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

9.  Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.

Authors:  C Conry-Cantilena; M VanRaden; J Gibble; J Melpolder; A O Shakil; L Viladomiu; L Cheung; A DiBisceglie; J Hoofnagle; J W Shih
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

10.  Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children.

Authors:  M E Lai; A P Mazzoleni; F Argiolu; S De Virgilis; A Balestrieri; R H Purcell; A Cao; P Farci
Journal:  Lancet       Date:  1994-02-12       Impact factor: 79.321
View more
  1 in total

Review 1.  Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.

Authors:  Evan B Cunningham; Tanya L Applegate; Andrew R Lloyd; Gregory J Dore; Jason Grebely
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.